These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14710127)

  • 1. Research on maternal and fetal safety after exposure to antidepressants in utero.
    Pinto N; Koren G
    Am J Obstet Gynecol; 2003 Dec; 189(6):1810-1; author reply 1811. PubMed ID: 14710127
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinuation syndrome following late pregnancy exposure to antidepressants.
    Koren G
    Arch Pediatr Adolesc Med; 2004 Apr; 158(4):307-8. PubMed ID: 15066865
    [No Abstract]   [Full Text] [Related]  

  • 3. Depression status as a confounder in the effects of antidepressants on the gestation age.
    Lan TH; Wu BJ; Chiu HJ; Hu TM; Tuan YC
    Am J Psychiatry; 2008 Mar; 165(3):399-400; author reply 400. PubMed ID: 18316436
    [No Abstract]   [Full Text] [Related]  

  • 4. Data directions.
    Schneiderman CP; Davis FG
    J Registry Manag; 2010; 37(1):30. PubMed ID: 20795568
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.
    Maschi S; Clavenna A; Campi R; Schiavetti B; Bernat M; Bonati M
    BJOG; 2008 Jan; 115(2):283-9. PubMed ID: 17903222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
    Nulman I; Rovet J; Stewart DE; Wolpin J; Pace-Asciak P; Shuhaiber S; Koren G
    Am J Psychiatry; 2002 Nov; 159(11):1889-95. PubMed ID: 12411224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature.
    Suri R; Lin AS; Cohen LS; Altshuler LL
    J Clin Psychiatry; 2014 Oct; 75(10):e1142-52. PubMed ID: 25373125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
    Lewis AJ; Galbally M; Opie G; Buist A
    Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation.
    Cantarutti A; Merlino L; Monzani E; Giaquinto C; Corrao G
    PLoS One; 2016; 11(12):e0168115. PubMed ID: 27977749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.
    Tak CR; Job KM; Schoen-Gentry K; Campbell SC; Carroll P; Costantine M; Brixner D; Birnbaum AK; Sherwin CMT
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1055-1069. PubMed ID: 28600701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of women suffering from depression who are either pregnant or breastfeeding.
    Yonkers KA
    Am J Psychiatry; 2007 Oct; 164(10):1457-9. PubMed ID: 17898329
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient pathological cardiotocography secondary to maternal drug abuse.
    Elkington NM; Mills M; Soothill P
    J Obstet Gynaecol; 2004 Feb; 24(2):182-3. PubMed ID: 14766466
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal adaptation following intrauterine antidepressant exposure: assessment, drug assay levels, and infant development outcomes.
    Galbally M; Spigset O; Johnson AR; Kohan R; Lappas M; Lewis AJ
    Pediatr Res; 2017 Nov; 82(5):806-813. PubMed ID: 28665925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental and fetal effects of antenatal exposure to antidepressants or untreated maternal depression.
    Gentile S; Fusco ML
    J Matern Fetal Neonatal Med; 2017 May; 30(10):1189-1199. PubMed ID: 27379818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Persistent Pulmonary Hypertension in Infants With the Timing and Type of Antidepressants In Utero.
    Munk-Olsen T; Bergink V; Rommel AS; Momen N; Liu X
    JAMA Netw Open; 2021 Dec; 4(12):e2136639. PubMed ID: 34851402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between antidepressant drug use during pregnancy and child healthcare utilisation.
    Ververs TF; van Wensen K; Freund MW; van der Heide M; Visser GH; Schobben AF; de Jong-van den Berg LT; Egberts AC
    BJOG; 2009 Nov; 116(12):1568-77. PubMed ID: 19681852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are antidepressants a risk for the fetus?].
    Nissen C
    MMW Fortschr Med; 2015 Jan; 157(1):30. PubMed ID: 25767866
    [No Abstract]   [Full Text] [Related]  

  • 18. Addressing environmentally caused human birth defects.
    Brent RL
    Pediatr Rev; 2001 May; 22(5):153-65. PubMed ID: 11331737
    [No Abstract]   [Full Text] [Related]  

  • 19. [Embryopathic alcoholism syndrome (alcoholic embryopathy)].
    Leiber B; Olbrich G
    Monatsschr Kinderheilkd (1902); 1976 Jan; 124(1):43-6. PubMed ID: 1246242
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of psychotropic medication during pregnancy and the postpartum period.
    Pearlstein T
    Womens Health (Lond); 2013 Nov; 9(6):605-15. PubMed ID: 24161312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.